India to Brazil: Fulvestrant Export Trade Route

The India to Brazil Fulvestrant corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $955.9K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's fulvestrant manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $56.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with fulvestrant's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 13.2%, placing it at rank #6 among India's top fulvestrant export destinations globally.

On the import side, key buyers of Indian fulvestrant in Brazil include DR REDDYS FARMACEUTICA DO BRASIL LIMITEDA, ACCORD FARMACEUTICA LIMITEDA, ACCORD FARMACEUTICA LTD and 6 others. DR REDDYS FARMACEUTICA DO BRASIL LIMITEDA is the single largest importer with 3 shipments valued at $197.7K USD.

India's fulvestrant exports to Brazil are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 79% of total trade value on this route. The average shipment value of $56.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drug&med: fulvestrant 250mg/5ml 1 and pharma drug&med: fulvestrant 250mg/5ml 1x2pfsac-br each pre filled syringe of5 ml contains: fulvestrant usp 250 mg re, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DR REDDYS FARMACEUTICA DO BRASIL LIMITEDA is the largest importer with 3 shipments worth $197.7K USD — representing 21% of all fulvestrant imports from India on this route. A total of 9 buyers are active on this corridor.